TY - JOUR
T1 - How do I initiate and maintain a mobile apheresis service in the era of cellular therapy
AU - Karasick, Michael H.
AU - Betancourt, Carolina
AU - Dormesy, Stephanie
AU - Sheehy, Jackie
AU - Isaacs, Rawlinson J.
AU - Sachais, Bruce S.
AU - Shi, Patricia A.
N1 - Funding Information:
We would like to acknowledge our wonderful apheresis staff, whose hard work is indispensable to the success of our apheresis service and Dorian Deschesne-Walsh for her creation of Figure S1.
Publisher Copyright:
© 2022 AABB.
PY - 2023/1
Y1 - 2023/1
N2 - Background: Mobile delivery of apheresis services is an increasingly important component of health care equity, as patients should not have to transfer care providers or travel far distances to receive critical therapeutic apheresis procedures or cell therapy-based treatments. Therefore, the availability of such services should be expanded. Study design and methods: In this “How Do I" article, we provide a detailed overview of the elements necessary to initiate and maintain a successful mobile apheresis service, including challenges and potential solutions. Results: Safe and efficient operation of a mobile apheresis service must consider acquisition of physical assets, such as apheresis sites, personnel, equipment and supplies, communication devices, and transportation vehicles, and optimize organizational aspects, such as staff responsibilities, service partnerships, logistics management, case scheduling and triage, and billing. In the era of cellular therapy, additional critical considerations include regulatory compliance and facility accreditation. Discussion: To our knowledge, no previous publication provides the extensive details described herein to set up and maintain a successful mobile apheresis service, and thus will be very helpful to those facilities wishing to initiate or expand mobile apheresis services.
AB - Background: Mobile delivery of apheresis services is an increasingly important component of health care equity, as patients should not have to transfer care providers or travel far distances to receive critical therapeutic apheresis procedures or cell therapy-based treatments. Therefore, the availability of such services should be expanded. Study design and methods: In this “How Do I" article, we provide a detailed overview of the elements necessary to initiate and maintain a successful mobile apheresis service, including challenges and potential solutions. Results: Safe and efficient operation of a mobile apheresis service must consider acquisition of physical assets, such as apheresis sites, personnel, equipment and supplies, communication devices, and transportation vehicles, and optimize organizational aspects, such as staff responsibilities, service partnerships, logistics management, case scheduling and triage, and billing. In the era of cellular therapy, additional critical considerations include regulatory compliance and facility accreditation. Discussion: To our knowledge, no previous publication provides the extensive details described herein to set up and maintain a successful mobile apheresis service, and thus will be very helpful to those facilities wishing to initiate or expand mobile apheresis services.
KW - apheresis
KW - cellular therapy
KW - mobile apheresis
KW - therapeutic apheresis
UR - http://www.scopus.com/inward/record.url?scp=85139526189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139526189&partnerID=8YFLogxK
U2 - 10.1111/trf.17143
DO - 10.1111/trf.17143
M3 - Article
C2 - 36208142
AN - SCOPUS:85139526189
SN - 0041-1132
VL - 63
SP - 13
EP - 22
JO - Transfusion
JF - Transfusion
IS - 1
ER -